PNC Financial Services Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5
Closed -$6K 4538
2021
Q3
$6K Hold
5
﹤0.01% 3887
2021
Q2
$7K Hold
5
﹤0.01% 3796
2021
Q1
$8K Sell
5
-25
-83% -$58.6K ﹤0.01% 3707
2020
Q4
$60K Sell
30
-30
-50% -$47.8K ﹤0.01% 2785
2020
Q3
$64K Buy
+60
New +$68.8K ﹤0.01% 2581
2020
Q1
Sell
-3
Closed -$3K 3976
2019
Q4
$3K Hold
3
﹤0.01% 3733
2019
Q3
$2K Hold
3
﹤0.01% 3861
2019
Q2
$3K Hold
3
﹤0.01% 3830
2019
Q1
$3K Hold
3
﹤0.01% 3833
2018
Q4
$2K Buy
+3
New +$3.15K ﹤0.01% 3859

Other funds holding LABU

PNC Financial Services Group's LABU Position: Q4 2021 in Review

PNC Financial Services Group sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2021, closing a stake of 5 shares — an estimated $6K sold.

PNC Financial Services Group first reported a position in LABU in Q4 2018 and held it in 10 quarters. The position peaked at $64K in Q3 2020. 33 funds tracked by Wall St. Rank hold LABU as of Q4 2021.

  • PNC Financial Services Group reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2021, an estimated $6K.
  • PNC Financial Services Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 10 quarters.
  • PNC Financial Services Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $64K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.